These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 22703863)

  • 1. Retrospective review of pelvic malignancies undergoing total pelvic exenteration.
    Kuhrt MP; Chokshi RJ; Arrese D; Martin EW
    World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of pelvic exenteration for locally advanced primary or recurrent non-colorectal pelvic malignancies.
    Ueda T; Koyama F; Nakagawa T; Nakamura S; Nishigori N; Inoue T; Kawasaki K; Obara S; Nakamoto T; Fujii H; Nakajima Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2433-6. PubMed ID: 24394136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-institution approach to total pelvic exenteration.
    Chokshi RJ; Fowler J; Cohn D; Bahnson R; Lumbley J; Martin EW
    Am Surg; 2011 Dec; 77(12):1629-39. PubMed ID: 22273221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 6. Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions.
    Iversen H; Martling A; Johansson H; Nilsson PJ; Holm T
    Colorectal Dis; 2018 May; 20(5):399-406. PubMed ID: 29161761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
    PelvExCollaborative
    Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genitourinary tract preservation versus pelvic exenteration for advanced colorectal tumors.
    Muruve N
    Can J Urol; 2003 Apr; 10(2):1815-8. PubMed ID: 12773233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Layer-oriented total pelvic exenteration for locally advanced primary colorectal cancer.
    Koda K; Shuto K; Matsuo K; Kosugi C; Mori M; Hirano A; Hiroshima Y; Tanaka K
    Int J Colorectal Dis; 2016 Jan; 31(1):59-66. PubMed ID: 26255259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic neoplasia.
    Carballo L; Enríquez-Navascués JM; Saralegui Y; Placer C; Timoteo A; Borda N; Carrillo A; Sainz-Lete A
    Cir Esp; 2015 Mar; 93(3):174-80. PubMed ID: 25443154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer.
    Jimenez RE; Shoup M; Cohen AM; Paty PB; Guillem J; Wong WD
    Dis Colon Rectum; 2003 Dec; 46(12):1619-25. PubMed ID: 14668586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
    Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
    Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration for advanced and recurrent malignancy.
    Zoucas E; Frederiksen S; Lydrup ML; Månsson W; Gustafson P; Alberius P
    World J Surg; 2010 Sep; 34(9):2177-84. PubMed ID: 20512493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
    Rottoli M; Vallicelli C; Boschi L; Poggioli G
    Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative pelvic exenteration: initial experience and clinical outcome.
    Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
    Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome.
    Bogner A; Fritzmann J; Müssle B; Huber J; Dobroschke J; Bork U; Wolk S; Distler M; Weitz J; Welsch T; Kahlert C
    Int J Colorectal Dis; 2021 Aug; 36(8):1701-1710. PubMed ID: 33677655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of advanced pelvic cancer by exenteration.
    Kecmanovic DM; Pavlov MJ; Kovacevic PA; Sepetkovski AV; Ceranic MS; Stamenkovic AB
    Eur J Surg Oncol; 2003 Nov; 29(9):743-6. PubMed ID: 14602493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total pelvic exenteration with or without sacral resection in patients with recurrent colorectal cancer.
    Sardi A; Bolton JS; Hicks TC; Skenderis BS
    South Med J; 1994 Mar; 87(3):363-9. PubMed ID: 7510906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration and sphincter preservation: an analysis of 96 cases.
    Poletto AH; Lopes A; Carvalho AL; Ribeiro EA; Vieira RA; Rossi BM; Aguiar S; Guimarães GC; Ferreira Fde O; Nakagawa WT
    J Surg Oncol; 2004 Jun; 86(3):122-7. PubMed ID: 15170649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.